{"id":914515,"date":"2025-12-01T07:33:19","date_gmt":"2025-12-01T12:33:19","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/"},"modified":"2025-12-01T07:33:19","modified_gmt":"2025-12-01T12:33:19","slug":"ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/","title":{"rendered":"IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics"},"content":{"rendered":"

<\/p>\n

IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics<\/b><\/p>\n

IonQ serves as strategic quantum technology partner across CCRM\u2019s leading global regenerative medicine network<\/i><\/p>\n

COLLEGE PARK, Md.–(BUSINESS WIRE<\/a>)–IonQ<\/b> (NYSE: IONQ), the world\u2019s leading quantum company, today announced an investment partnership with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate next-generation therapeutic development using hybrid quantum and quantum-AI technologies. The partnership includes an investment commitment into CCRM\u2019s new quantum-biotech initiatives and establishes IonQ as the core technology partner across CCRM\u2019s global network of advanced therapy hubs.\n<\/p>\n

This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20251201706303\/en\/<\/a><\/p>\n

\"IonQ<\/p>\n

IonQ serves as strategic quantum technology partner across CCRM\u2019s leading global regenerative medicine network.<\/p>\n<\/div>\n

\nWith more than 100,000 square feet of good manufacturing practice (GMP) facilities, 300+ scientific staff and a global network of academic and industry partners, CCRM is one of the world\u2019s leading accelerators for advanced therapies. CCRM was established in 2011 in Toronto, Canada, to realize the promise of regenerative medicine and deliver durable treatments, and even cures, for the world\u2019s most debilitating chronic diseases. CCRM\u2019s extensive global network of academic researchers, industry partners, and investors will work closely with IonQ to revolutionize medicine and provide unmatched computational advantages to its members.\n<\/p>\n

\n\u201cIonQ\u2019s quantum technologies are poised to reshape industries, and health care is one of the most exciting frontiers,\u201d states Niccolo de Masi, Chairman and CEO of IonQ. \u201cTogether with CCRM and its global partners, we will identify, test, and deploy breakthrough applications that will transform therapeutic development, biomanufacturing, and delivery for patients across the globe.\u201d\n<\/p>\n

\nThis collaboration will initially focus on areas including bioprocess optimization, disease-modeling workflows, and quantum enhanced simulation to support the design and manufacturing of advanced therapies. By bringing together CCRM\u2019s expertise in next-generation therapeutic innovation and IonQ\u2019s unparalleled leadership in cutting-edge quantum technologies, the partnership aims to address some of the most pressing challenges in health care and life sciences. Initial projects will be launched in both Canada and Sweden in 2026.\n<\/p>\n

\n\u201cBy combining our strengths,\u201d says Michael May, President and CEO of CCRM, \u201cwe are uniquely positioned to unlock solutions that were previously beyond reach. Just as CCRM focused on biomanufacturing 15 years ago, this frontier-of-science collaboration will help accelerate the discovery and application of advanced therapies, with the potential to make a real difference for patients worldwide. We are very excited by this opportunity and collaboration with IonQ.\u201d\n<\/p>\n

\n\u201cLike Canada, Sweden has identified advanced therapies and quantum computing as areas of high priority for development and commercialization,\u201d says Fredrik Wessberg, CEO of CCRM Nordic. \u201cThis partnership will help demonstrate the value of the CCRM network of hubs, and the need for global collaboration to deliver complex health care modalities to patients globally.\u201d\n<\/p>\n

\nToday\u2019s announcement builds on IonQ\u2019s recent collaboration with AstraZeneca<\/a> to establish a new quantum application development center in Sweden within AstraZeneca\u2019s BioVenture Hub. Earlier this year IonQ announced that with the acquisition of Oxford Ionics<\/a> it would expand R&D and quantum engineering teams in Oxford. IonQ also established a long-term partnership with Einride<\/a> in Stockholm, Sweden in April 2025. In 2024, IonQ established its first European Innovation Center<\/a> at QuantumBasel in Switzerland, and the company completed its acquisition of Switzerland-based IDQ<\/a>.\n<\/p>\n

About IonQ<\/b><\/p>\n

IonQ, Inc.<\/a> [NYSE: IONQ] is the world\u2019s leading quantum company delivering solutions to solve the world\u2019s most complex problems. IonQ\u2019s newest generation of quantum computers, IonQ Forte<\/a> and IonQ Forte Enterprise<\/a>, are the latest in a line of cutting-edge systems that have been helping customers and partners such as Amazon Web Services, AstraZeneca, and NVIDIA<\/a> achieve 20x performance results. The company achieved 99.99% two-qubit gate fidelity, setting a world record in quantum computing performance in 2025<\/a>.\n<\/p>\n

\nThe company is accelerating its technology roadmap and intends to deliver the world\u2019s most powerful quantum computers with 2 million qubits by 2030 to accelerate innovation in drug discovery, materials science, financial modeling, logistics, cybersecurity, and defense. IonQ\u2019s advancements in quantum networking also position the company as a leader in building the quantum internet.\n<\/p>\n

\nIonQ has operations in Maryland, Washington, California, Colorado, Massachusetts, Tennessee, United Kingdom, Toronto, South Korea, Sweden, and Switzerland. The company\u2019s innovative technology and rapid growth were recognized in Fortune Future 50, Newsweek\u2019s 2025 Excellence Index 1000, and Forbes\u2019 2025 Most Successful Mid-Cap Companies list. Available through all major cloud providers, IonQ is making quantum more accessible and impactful than ever before. Learn more at IonQ.com<\/a>.\n<\/p>\n

IonQ\u2019s Forward-Looking Statements<\/b><\/p>\n

\nThis press release contains forward-looking statements. All statements contained in this press release other than statements of historical fact are forward-looking statements, including statements regarding our expectations regarding the closing of various acquisitions and their impact on our business. In some cases, you can identify these statements by forward-looking words such as \u201cpending,\u201d \u201clook forward,\u201d \u201caccelerate,\u201d \u201canticipate,\u201d \u201cexpect,\u201d \u201csuggest,\u201d \u201cplan,\u201d \u201cbelieve,\u201d \u201cintend,\u201d \u201cestimate,\u201d \u201ctarget,\u201d \u201cproject,\u201d \u201cshould,\u201d \u201ccould,\u201d \u201cwould,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201cforecast,\u201d \u201cconfident\u201d and other similar expressions. These statements are only predictions based on our expectations and projections about future events as of the date of this press release and are subject to a number of risks, uncertainties and assumptions that may prove incorrect, any of which could cause actual results to differ materially from those expressed or implied by such statements, including, among others, those described under the heading \u201cRisk Factors\u201d in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the Securities and Exchange Commission, or SEC, and our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025, June 30, 2025 and September 30, 2025 filed with the SEC. New risks emerge from time to time, and it is not possible for our management to predict all risks, nor can management assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statement we make. Investors are cautioned not to place undue reliance on any such forward-looking statements, which speak only as of the date they are made. Except as otherwise required by law, we undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20251201706303\/en\/<\/a><\/span><\/p>\n

IonQ Media contacts:
\n<\/b>
Cheryl Krauss
\n
cheryl.krauss@ionq.co<\/a><\/p>\n

\nTor Constantino
\n
tor.constantino@ionq.co<\/a><\/p>\n

IonQ Investor Contact:
\n<\/b>
investors@ionq.co<\/a><\/p>\n

KEYWORDS:<\/b> Maryland North America United States Europe Sweden Canada<\/p>\n

INDUSTRY KEYWORDS:<\/b> Software Research Other Health Networks Pharmaceutical Technology Artificial Intelligence Semiconductor Science Biotechnology Other Technology Health Other Science<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n\n\n\n
Photo<\/b><\/font><\/td>\n<\/tr>\n
\"Photo\"<\/td>\n<\/tr>\n
IonQ serves as strategic quantum technology partner across CCRM\u2019s leading global regenerative medicine network.<\/font><\/td>\n<\/tr>\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics IonQ serves as strategic quantum technology partner across CCRM\u2019s leading global regenerative medicine network COLLEGE PARK, Md.–(BUSINESS WIRE)–IonQ (NYSE: IONQ), the world\u2019s leading quantum company, today announced an investment partnership with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate next-generation therapeutic development using hybrid quantum and quantum-AI technologies. The partnership includes an investment commitment into CCRM\u2019s new quantum-biotech initiatives and establishes IonQ as the core technology partner across CCRM\u2019s global network of advanced therapy hubs. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20251201706303\/en\/ IonQ serves as strategic quantum technology partner across CCRM\u2019s leading global regenerative medicine network. With more than 100,000 square … <\/p>\n

Continue reading “IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-914515","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nIonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics IonQ serves as strategic quantum technology partner across CCRM\u2019s leading global regenerative medicine network COLLEGE PARK, Md.–(BUSINESS WIRE)–IonQ (NYSE: IONQ), the world\u2019s leading quantum company, today announced an investment partnership with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate next-generation therapeutic development using hybrid quantum and quantum-AI technologies. The partnership includes an investment commitment into CCRM\u2019s new quantum-biotech initiatives and establishes IonQ as the core technology partner across CCRM\u2019s global network of advanced therapy hubs. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20251201706303\/en\/ IonQ serves as strategic quantum technology partner across CCRM\u2019s leading global regenerative medicine network. With more than 100,000 square … Continue reading "IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-01T12:33:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251201706303\/en\/2656500\/4\/IonQ-CCRM_Logo_Lockup3.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics\",\"datePublished\":\"2025-12-01T12:33:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\\\/\"},\"wordCount\":1135,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251201706303\\\/en\\\/2656500\\\/4\\\/IonQ-CCRM_Logo_Lockup3.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\\\/\",\"name\":\"IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251201706303\\\/en\\\/2656500\\\/4\\\/IonQ-CCRM_Logo_Lockup3.jpg\",\"datePublished\":\"2025-12-01T12:33:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251201706303\\\/en\\\/2656500\\\/4\\\/IonQ-CCRM_Logo_Lockup3.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251201706303\\\/en\\\/2656500\\\/4\\\/IonQ-CCRM_Logo_Lockup3.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics - Market Newsdesk","og_description":"IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics IonQ serves as strategic quantum technology partner across CCRM\u2019s leading global regenerative medicine network COLLEGE PARK, Md.–(BUSINESS WIRE)–IonQ (NYSE: IONQ), the world\u2019s leading quantum company, today announced an investment partnership with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate next-generation therapeutic development using hybrid quantum and quantum-AI technologies. The partnership includes an investment commitment into CCRM\u2019s new quantum-biotech initiatives and establishes IonQ as the core technology partner across CCRM\u2019s global network of advanced therapy hubs. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20251201706303\/en\/ IonQ serves as strategic quantum technology partner across CCRM\u2019s leading global regenerative medicine network. With more than 100,000 square … Continue reading \"IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/","og_site_name":"Market Newsdesk","article_published_time":"2025-12-01T12:33:19+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251201706303\/en\/2656500\/4\/IonQ-CCRM_Logo_Lockup3.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics","datePublished":"2025-12-01T12:33:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/"},"wordCount":1135,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251201706303\/en\/2656500\/4\/IonQ-CCRM_Logo_Lockup3.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/","name":"IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251201706303\/en\/2656500\/4\/IonQ-CCRM_Logo_Lockup3.jpg","datePublished":"2025-12-01T12:33:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251201706303\/en\/2656500\/4\/IonQ-CCRM_Logo_Lockup3.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251201706303\/en\/2656500\/4\/IonQ-CCRM_Logo_Lockup3.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ionq-and-ccrm-announce-strategic-quantum-biotech-collaboration-to-accelerate-development-of-advanced-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"IonQ and CCRM Announce Strategic Quantum-Biotech Collaboration to Accelerate Development of Advanced Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/914515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=914515"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/914515\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=914515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=914515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=914515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}